Abstract Details
|
Adrienne Daebrich
PRESENTER |
No disclosure on file |
| Daniel Woo, MD, FAAN (University at Buffalo) | The institution of Dr. Woo has received research support from NIH. |
| No disclosure on file | |
| Stephen Wanaski, PhD (Paragon Biosciences) | Dr. Wanaski has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Wanaski has stock in Paragon Biosciences. Dr. Wanaski has stock in Emalex Biosciences. |
| No disclosure on file | |
| Matthew L. Flaherty, MD | Dr. Flaherty has received personal compensation for serving as an employee of Sense Diagnostics, Inc. Dr. Flaherty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boeringher Engelheim. Dr. Flaherty has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Flaherty has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alexion. Dr. Flaherty has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Flaherty has stock in Sense Diagnostics, Inc. The institution of Dr. Flaherty has received research support from NINDS. Dr. Flaherty has received intellectual property interests from a discovery or technology relating to health care. |
| Jennifer Osborne, NP (University of Cincinnati) | No disclosure on file |